| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in Frontline Management of Peripheral T-cell Lymphoma
|
Abeyakoon, Chathuri
|
|
|
21 |
6 |
p. 368-378
|
artikel
|
| 2 |
Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia
|
Shin, Hyejin
|
|
|
21 |
6 |
p. e521-e529
|
artikel
|
| 3 |
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma
|
Demonchy, Jordane
|
|
|
21 |
6 |
p. e545-e547
|
artikel
|
| 4 |
Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges
|
Singh, Suvir
|
|
|
21 |
6 |
p. e569-e578
|
artikel
|
| 5 |
Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis
|
Acevedo, Jose
|
|
|
21 |
6 |
p. 425-426
|
artikel
|
| 6 |
Clinical Outcomes Associated With Chronic Kidney Disease in Elderly Medicare Patients With Multiple Myeloma
|
Li, Shuling
|
|
|
21 |
6 |
p. 401-412.e24
|
artikel
|
| 7 |
Comparison of Azacitidine and Decitabine in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Network Meta-analysis
|
Liu, Weiyang
|
|
|
21 |
6 |
p. e530-e544
|
artikel
|
| 8 |
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia
|
Al-Shaibani, Eshrak
|
|
|
21 |
6 |
p. e559-e568
|
artikel
|
| 9 |
Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy
|
Hoffmann, Marc S.
|
|
|
21 |
6 |
p. e548-e550
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
21 |
6 |
p. A4-A5
|
artikel
|
| 11 |
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies
|
Gesiotto, Quinto J.
|
|
|
21 |
6 |
p. 421-424.e2
|
artikel
|
| 12 |
Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series
|
Truong, Huong
|
|
|
21 |
6 |
p. e497-e502
|
artikel
|
| 13 |
Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance
|
Georgakopoulou, Rebecca
|
|
|
21 |
6 |
p. 361-367
|
artikel
|
| 14 |
Patterns of Care for Older Patients With Myelofibrosis: A Population-based Study
|
Meckstroth, Shelby
|
|
|
21 |
6 |
p. e551-e558
|
artikel
|
| 15 |
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
|
Rodriguez-Otero, Paula
|
|
|
21 |
6 |
p. 413-420
|
artikel
|
| 16 |
Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia
|
Reid, Justin H.
|
|
|
21 |
6 |
p. 393-400.e1
|
artikel
|
| 17 |
Real-World Treatment of Patients With Relapsed/Refractory Myeloma
|
Ntanasis-Stathopoulos, Ioannis
|
|
|
21 |
6 |
p. 379-385
|
artikel
|
| 18 |
Severe and Irreversible Pancytopenia Associated With SARS-CoV-2 Bone Marrow Infection in a Patient With Waldenstrom Macroglobulinemia
|
Velier, Mélanie
|
|
|
21 |
6 |
p. e503-e505
|
artikel
|
| 19 |
Successful Treatment of TCF3-HLF–positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy
|
Wang, Tianyi
|
|
|
21 |
6 |
p. 386-392
|
artikel
|
| 20 |
Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma
|
Lebel, Eyal
|
|
|
21 |
6 |
p. e506-e509
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
21 |
6 |
p. A6-A8, A10
|
artikel
|
| 22 |
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR)
|
Bergin, Krystal
|
|
|
21 |
6 |
p. e510-e520
|
artikel
|
| 23 |
To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report
|
Khalife, Roy
|
|
|
21 |
6 |
p. e493-e496
|
artikel
|
Tijdschrift beschrijving